Carey and Andes IP advised on the deal
Ingalfarma finalized the merger agreement with Level Bioscience.
Based in Chile, Ingalfarma is a biomedical company that develops innovative treatments aimed at solving complex oral pathologies.
Level Bioscience engages in research on opportunity offerted by the use of statin for oral health .
Carey advised Ingalfarma with Francisco Guzmán (Picture) and Nicolás Calderón.
Andes IP advised Level Bioscience with Andrea Lobos, Felipe Burgos Osorio and Rodrigo Sammut Linares.